Abstract
PURPOSE: Continuous β-agonist therapy, typically in the form of inhaled albuterol, is common for the treatment of acute bronchospasm in children. Although this treatment is thought to carry minimal risk, concerns about potential cardiotoxicity have been raised. The purpose of this pilot study was to determine the cardiotoxic effects of continuous β-agonist therapy in children.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
